Samsung’s Xealth Acquisition Sets New Benchmark in Digital Health Integration
Samsung Electronics has taken a decisive step to redefine the digital health landscape with its acquisition of Xealth, a U.S.-based healthcare integration platform. The deal, announced on July 8, 2025, is set to close by year-end and marks a major milestone in Samsung’s ongoing transformation from a consumer electronics giant to a leader in connected healthcare services.
Xealth, founded in 2016 as a spin-off from Providence Health & Services, is a recognized force in digital health, partnering with over 500 hospitals and supporting more than 70 digital health solutions across areas like diabetes, pregnancy, and post-surgical care. Its platform enables clinicians to prescribe, monitor, and track digital health apps and content in real time, bridging the gap between hospital-based care and patients’ daily wellness routines. This integration is designed to empower physicians to recommend targeted digital interventions—such as mobile apps for blood sugar management or recovery programs—directly through electronic health records while monitoring patient engagement and outcomes.
Samsung’s acquisition strategy aims to build an integrated connected care platform. By fusing Xealth’s clinical integration capabilities with Samsung’s leadership in wearables—spanning Galaxy smartwatches, the new Galaxy Ring, and a broad portfolio of smart home devices—Samsung aims to unify fragmented health data and deliver hyper-personalized, preventive care at scale. The company envisions a future where biometric data from wearables flows directly into clinical workflows, making health tracking actionable for both patients and providers and enabling tailored interventions that can prevent disease and improve long-term outcomes.
This move is not Samsung’s first foray into emerging tech sectors, but it is its boldest yet in digital health. Recent acquisitions in robotics, AI, and medical technology signal Samsung’s intent to build a robust, future-ready ecosystem. TM Roh, president and acting head of Samsung’s Device eXperience Division, emphasized that the Xealth deal will be “an anchor to accelerate Samsung’s efforts to support health systems and digital health partners through truly connected care.”
Mike McSherry, CEO and co-founder of Xealth, commented on the acquisition:
“Joining forces with Samsung accelerates our mission to simplify digital health adoption and empower care teams to engage patients more effectively. Together, we have a unique opportunity to make personalized care seamless, actionable, and accessible at a global scale.” This alignment of vision underscores both companies’ commitment to bridging the gap between hospital-directed interventions and everyday wellness tools.
The timing of this acquisition could not be more strategic. According to MarketsandMarkets, the global digital health market is experiencing explosive growth, projected to reach USD 549.7 billion by 2028, fueled by rising adoption of telehealth, wearable devices, and AI-driven patient engagement solutions. The integration of clinical and consumer health data is a critical differentiator in this space, and Samsung’s expanded ecosystem positions it at the forefront of this transformation.
Samsung’s vision is clear: to empower individuals to take control of their health by breaking down silos between wellness and medical care, and to make digital health tools accessible through relentless innovation and open collaboration. As the digital health market accelerates, all eyes will be on how Samsung leverages Xealth’s platform to deliver on the promise of connected care, ultimately shaping the future of healthcare delivery.
The transaction is expected to close by the end of 2025, subject to customary regulatory reviews in the United States, particularly in relation to data privacy protections under HIPAA and emerging standards for health information interoperability. Industry experts note that integrating consumer-grade wearables into regulated clinical workflows will require rigorous safeguards for cybersecurity and compliance, as well as sustained collaboration with health system partners to ensure adoption at scale.
MarketsandMarkets Industry News Desk
Letter to EditorGET AHEAD
Top Research Reports to Fuel Your Industry KnowledgeEditor's Pick
Healthcare
Samsung’s Xealth Acquisition Sets New Benchmark in Digital Health Integration
Information and Communication Technology
Revolutionizing B2B Sales Prospecting with AI-Powered Pipeline Intelligence from SalesPlay
Information and Communication Technology
Why Apple’s Interest in Perplexity Could Redefine Generative AI StrategyPODCASTS
Sustainable Digital Transformation & Industry 4.0
Sanjay Kaul, President-Asia Pacific & Japan, Cisco, and host Aashish Mehra, Chief Research Officer, MarketsandMarkets, in conversation on unraveling 'Sustainable Digital Transformation and Industry 4.0'
11 July 2023|S2E12|Listen Now
Generative AI
Prasad Joshi, Senior Vice President-Emerging Technology Solutions, Infosys, and host, Vinod Chikkareddy, CCO, MarketsandMarkets, in exploring the recent advances in AI and the generative AI space.
7 Nov 2023|S2E13|Listen Now
Digital Health Market: Growth, Size, Share, and Trends
Samsung’s Xealth Acquisition Sets New Benchmark for Connected Digital Health
Samsung’s acquisition of Xealth positions it to seamlessly integrate clinical care with consumer wearables, creating an unprecedented connected health ecosystem. This move empowers healthcare providers to prescribe personalized digital interventions and track outcomes in real time, accelerating the shift toward preventive, data-driven care on a global scale.
The Road to Integration: Xealth’s Rise and Samsung’s Vision
Founded in 2016 as a spin-off from Providence Health & Services, Xealth emerged to address a critical gap in digital health adoption.
